Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kocák

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2010
[Hand-foot syndrome after administration of tyrosinkinase inhibitors]D Bednaríková, I Kocák
Folia Biologica|September 16, 2003
Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patientsV Boudný, I Kocák, L Lauerová, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Review of combined chemoradiotherapy in the treatment of esophageal carcinoma]I Kocáková, R Soumarová, I Kocák, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Concomitant preoperative chemoradiotherapy in the treatment of anal carcinoma]I Kocáková, I Kocák, R Vyzula, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Role of concomitant chemoradiotherapy in the treatment algorithm for rectal carcinoma]I Kocáková, J Růzicková, I Kocák, et al.
Vnitrni Lekarstvi|March 1, 1997
[Cytokines in regional immunochemotherapy of liver tumors]J Zaloudík, P Karásek, I Kocák, et al.
Vnitrni Lekarstvi|October 25, 2000
[Treatment with interferon and autoimmunity]A Gaja, H Franková, I Kocák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 16, 2009
[Bevacizumab in combination with capecitabine and irinotecan (XELIRI) in treatment of metastatic colorectal cancer]I Kocáková, I Kocák, M Svoboda, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Genetic background of cisplatin induced ototoxicity]M Jurajda, T Talach, R Kostřica, et al.
Neoplasma|July 5, 2002
Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy responseL Lauerova, L Dusek, M Simickova, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2010
[Hand-foot syndrome after administration of tyrosinkinase inhibitors]D Bednaríková, I Kocák
Folia Biologica|September 16, 2003
Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patientsV Boudný, I Kocák, L Lauerová, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Review of combined chemoradiotherapy in the treatment of esophageal carcinoma]I Kocáková, R Soumarová, I Kocák, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Concomitant preoperative chemoradiotherapy in the treatment of anal carcinoma]I Kocáková, I Kocák, R Vyzula, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Role of concomitant chemoradiotherapy in the treatment algorithm for rectal carcinoma]I Kocáková, J Růzicková, I Kocák, et al.
Vnitrni Lekarstvi|March 1, 1997
[Cytokines in regional immunochemotherapy of liver tumors]J Zaloudík, P Karásek, I Kocák, et al.
Vnitrni Lekarstvi|October 25, 2000
[Treatment with interferon and autoimmunity]A Gaja, H Franková, I Kocák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 16, 2009
[Bevacizumab in combination with capecitabine and irinotecan (XELIRI) in treatment of metastatic colorectal cancer]I Kocáková, I Kocák, M Svoboda, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Genetic background of cisplatin induced ototoxicity]M Jurajda, T Talach, R Kostřica, et al.
Neoplasma|July 5, 2002
Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy responseL Lauerova, L Dusek, M Simickova, et al.
Pageof 3